[1]BioorganicandMedicinalChemistryLetters,2007,vol.17,#11,p.3177-3180
[1]BulletindesSocietesChimiquesBelges,1960,vol.69,p.312-322
[1]ChemischeBerichte,1936,vol.69,p.2253,2255
[1]JournaloftheAmericanChemicalSociety,1985,vol.107,p.1556-1561
[1]ChemischeBerichte,1936,vol.69,p.2253,2255
[2]JournaloftheAmericanChemicalSociety,1960,vol.82,p.99-104
[3]TheJournalofpharmacyandpharmacology,1962,vol.14,p.587-596
[4]BioorganicandMedicinalChemistryLetters,2007,vol.17,#11,p.3177-3180
[1]BulletindesSocietesChimiquesBelges,1960,vol.69,p.312-322
[1]BulletindesSocietesChimiquesBelges,1960,vol.69,p.312-322
[2]BioorganicandMedicinalChemistryLetters,2007,vol.17,p.3177-3180
[3]JournaloftheAmericanChemicalSociety,1960,vol.82,p.99-104
[1]JournaloftheAmericanChemicalSociety,1985,vol.107,p.1556-1561
[1]JournalofMedicinalChemistry,1991,vol.34,p.217-222
[1]Patent:US2008/51585,2008,A1.Locationinpatent:Page/Pagecolumn18
[2]Synthesis,1991,p.871-878
[3]Patent:US2013/274253,2013,A1.Locationinpatent:Paragraph1331-1338
Title: 4-Chloro-3-fluoro-2-methyl-aniline-pyrrolidine-2,5-dione (1/1).
Journal: Acta crystallographica. Section E, Structure reports online 20080701